Ocular Therapeutix
OCUL
$5.56
Share price
10.86%
Change (1 day)
-9.95%
Change (1 year)
Categories
Operating Margin for Ocular Therapeutix (OCUL)
Operating Margin as of May 2024 (TTM): -171.85%
According to Ocular Therapeutix's latest financial reports and stock price the company's current Operating Margin is -171.85%. At the end of 2021 the company had an Operating Margin of -15.06%.
Operating Margin history for Ocular Therapeutix from 2014 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -15.06% | -98.32% |
| 2020 | -894.31% | -56.23% |
| 2019 | -2,043.34% | -32.2% |
| 2018 | -3,013.97% | -8.56% |
| 2017 | -3,296.20% | 39.14% |
| 2016 | -2,369.00% | 4.3% |
| 2015 | -2,271.31% | -38.79% |
| 2014 | -3,710.88% | |
| 2012 | -140,930.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | -22.50% | -86.91% | 🇺🇸 USA |
 Anika Therapeutics ANIK | 1.64% | -100.95% | 🇺🇸 USA |
 Intersect ENT XENT | -156.32% | -9.04% | 🇺🇸 USA |
 Haemonetics HAE | 12.09% | -107.04% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.